Home
Novartis India Ltd Share Price History
Novartis India Ltd
NSE : 25 Oct, 2023
672.25-17.1 (-2.5%)
Prev Close
689.3
Open Price
691.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
21747
Today's High / Low
698.2 / 668.3
52 WK High / Low
698.2 / 0.0
Market Price of Novartis India Ltd
1M
1Y
3Y
5Y
Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 656 |
| Sales YoY Gr. | - |
| Adj EPS | 20.33 |
| YoY Gr. | - |
| Net Profit (Cr.) | 57 |
| BVPS | 326.81 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 8.42 |
| Op. Profit Mgn % | 14.64 |
| Net Profit Mgn % | 8.72 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Novartis India Ltd
- Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
- The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
- The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
- In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
- In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.
Popular Search
FAQs for Novartis India Ltd Share Price History
What are the key events that typically impact Novartis India Ltd's share price history?
Key events that impact Novartis India Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Novartis India Ltd's share price history?
Stock splits reduce the nominal price of Novartis India Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Novartis India Ltd?
Dividends can influence Novartis India Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Novartis India Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Novartis India Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Novartis India Ltd’s share price history?
To understand Novartis India Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
